These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. [Clinical usefulness of 99mTc-PMT whole body scans in the diagnosis of bone metastases from hepatocellular carcinoma]. Nakanishi Y; Ha-Kawa SK Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Feb; 52(2):208-16. PubMed ID: 1313962 [TBL] [Abstract][Full Text] [Related]
67. Clinical significance of hepatic visualization on iodine-131 whole-body scan in patients with thyroid carcinoma. Chung JK; Lee YJ; Jeong JM; Lee DS; Lee MC; Cho BY; Koh CS J Nucl Med; 1997 Aug; 38(8):1191-5. PubMed ID: 9255147 [TBL] [Abstract][Full Text] [Related]
71. [A case of multiple primary cancers, hepatoma and seminoma, detected by 67Ga citrate and 99mTc-HIDA scintigraphy]. Hiraki Y; Nakajo M; Uchiyama N Kaku Igaku; 1991 Dec; 28(12):1497-502. PubMed ID: 1664471 [TBL] [Abstract][Full Text] [Related]
72. Technetium-99m glucoheptonate as a scanning agent in hepatocellular carcinoma. Esser JD; Kew MC; Tobias M; Winterton R; Savitch I; Levin J Clin Nucl Med; 1985 Aug; 10(8):586-8. PubMed ID: 2994936 [TBL] [Abstract][Full Text] [Related]
73. 99mTc EDHP bone scintiscans in healthy young adults and patients with Reiter's syndrome. Bandilla KK Ann Rheum Dis; 1979; 38 Suppl 1(Suppl 1):suppl 38. PubMed ID: 122436 [No Abstract] [Full Text] [Related]
74. Comparison of radionuclide imaging and ultrasonography of the liver. Elyaderani MK; Gabriele OF South Med J; 1983 Jan; 76(1):37-44. PubMed ID: 6823576 [TBL] [Abstract][Full Text] [Related]
75. [Clinical studies on bone deposition of 99mTc-labeled-DPD (dicarboxypropane diphosphonate): a comparison with 99mTc-methylene diphosphonate]. Otsuka N; Yoneda M; Sawai M; Saito J; Nagai K; Muranaka A; Terashima H; Yanagimoto S; Ito Y Kaku Igaku; 1982 Dec; 19(10):1573-8. PubMed ID: 6221135 [No Abstract] [Full Text] [Related]
76. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model. Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299 [TBL] [Abstract][Full Text] [Related]
77. "Hot spot" on the colloid liver scan observed in a case of bronchogenic cancer with superior vena caval obstruction. Imajo Y; Takashima H; Ogawa Y; Gose K; Imanaka K; Oshitani T; Matsuo M; Sako M; Nishiyama S Radioisotopes; 1979 Jul; 28(7):450-2. PubMed ID: 504728 [No Abstract] [Full Text] [Related]
78. [A comparison of 201Tl and 99mTc-MIBI in the follow-up of differentiated thyroid carcinomas]. Briele B; Hotze A; Kropp J; Bockisch A; Overbeck B; Grünwald F; Kaiser W; Biersack HJ Nuklearmedizin; 1991 Aug; 30(4):115-24. PubMed ID: 1788076 [TBL] [Abstract][Full Text] [Related]
79. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals. Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298 [TBL] [Abstract][Full Text] [Related]
80. Biokinetics of bone tracers by means of deconvolution analysis--comparison of 99mTc MDP, 99mTc DPD and 99mTc EHDP. Knop J; Stritzke P; Kröger E; Schneider C; Wasmus G Nuklearmedizin; 1982 Aug; 21(4):145-9. PubMed ID: 6216459 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]